Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C8H11N3O6 |
| Molecular Weight | 245.1894 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2N=CC(=O)NC2=O
InChI
InChIKey=WYXSYVWAUAUWLD-SHUUEZRQSA-N
InChI=1S/C8H11N3O6/c12-2-3-5(14)6(15)7(17-3)11-8(16)10-4(13)1-9-11/h1,3,5-7,12,14-15H,2H2,(H,10,13,16)/t3-,5-,6-,7-/m1/s1
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Insights into arbovirus evolution and adaptation from experimental studies. | 2010-12 |
|
| Historical perspectives in the development of antiviral agents against poxviruses. | 2010-06 |
|
| Triplet formation of 6-azauridine and singlet oxygen sensitization with UV light irradiation. | 2010-05-21 |
|
| Six RNA viruses and forty-one hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems. | 2010-02-12 |
|
| Antiviral activity of indole derivatives. | 2009-08 |
|
| Antiviral and cytotoxic activities of aminoarylazo compounds and aryltriazene derivatives. | 2009-07-01 |
|
| Hepatoprotective Activity of Licorice Water Extract against Cadmium-induced Toxicity in Rats. | 2009-06 |
|
| Recognition of acyl donors by lipase CAL-B in the acylation of 6-azauridine. | 2009-05-20 |
|
| Transcript elongation factor TFIIS is involved in arabidopsis seed dormancy. | 2009-02-27 |
|
| Antimicrobial and cytotoxic arylazoenamines. Part III: antiviral activity of selected classes of arylazoenamines. | 2008-09-15 |
|
| N-methylisatin-beta-thiosemicarbazone derivative (SCH 16) is an inhibitor of Japanese encephalitis virus infection in vitro and in vivo. | 2008-05-22 |
|
| Structure and inhibition of orotidine 5'-monophosphate decarboxylase from Plasmodium falciparum. | 2008-03-25 |
|
| 6-Azauracil or 8-aza-7-deazaadenine nucleosides and oligonucleotides: the effect of 2'-fluoro substituents and nucleobase nitrogens on conformation and base pairing. | 2008-02-07 |
|
| Azacytidine (Vidaza(R)) in the treatment of myelodysplastic syndromes. | 2006-12 |
|
| Broad-spectrum inhibitor of viruses in the Flaviviridae family. | 2005-11 |
|
| Synthesis of N3-substituted uridine and related pyrimidine nucleosides and their antinociceptive effects in mice. | 2005-03 |
|
| [Biotechnological synthesis of ribavirin. Effect of ribavirin and its various combinations on the reproduction of Vaccinia virus]. | 2004-12-14 |
|
| Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy. | 2004-04-05 |
|
| A simple assay for determining antiviral activity against Crimean-Congo hemorrhagic fever virus. | 2004-04 |
|
| In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination. | 2004-02 |
|
| Use of nucleotide analogs by class I and class II CCA-adding enzymes (tRNA nucleotidyltransferase): deciphering the basis for nucleotide selection. | 2003-08 |
|
| Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. | 2003-06-14 |
|
| Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses. | 2003-03 |
|
| Comparison of colorimetric, fluorometric, and visual methods for determining anti-influenza (H1N1 and H3N2) virus activities and toxicities of compounds. | 2002-10 |
|
| Identification of active antiviral compounds against a New York isolate of West Nile virus. | 2002-07 |
|
| In vitro metabolism studies of the prodrug, 2',3',5'-triacetyl-6-azauridine, utilizing an automated analytical system. | 2001-12 |
|
| Site specific incorporation of 6-azauridine into the genomic HDV ribozyme active site. | 2001-11-27 |
|
| Enantiomeric synthesis of D- and L-cyclopentenyl nucleosides and their antiviral activity against HIV and West Nile virus. | 2001-11-08 |
|
| Antiviral activity and mode of action studies of ribavirin and mycophenolic acid against orthopoxviruses in vitro. | 2001-11 |
|
| Phosphorylation of uridine and cytidine nucleoside analogs by two human uridine-cytidine kinases. | 2001-05 |
|
| Inhibition of sandfly fever Sicilian virus (Phlebovirus) replication in vitro by antiviral compounds. | 1997-12-24 |
|
| Inhibitory effect of selected antiviral compounds on measles (SSPE) virus replication in vitro. | 1989-09 |
|
| 6-Azauridine in combination chemotherapy of childhood acute myelocytic leukemia. | 1972-04 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C2170
Created by
admin on Mon Mar 31 17:47:25 GMT 2025 , Edited by admin on Mon Mar 31 17:47:25 GMT 2025
|
||
|
NCI_THESAURUS |
C1557
Created by
admin on Mon Mar 31 17:47:25 GMT 2025 , Edited by admin on Mon Mar 31 17:47:25 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
35668
Created by
admin on Mon Mar 31 17:47:25 GMT 2025 , Edited by admin on Mon Mar 31 17:47:25 GMT 2025
|
PRIMARY | |||
|
32074
Created by
admin on Mon Mar 31 17:47:25 GMT 2025 , Edited by admin on Mon Mar 31 17:47:25 GMT 2025
|
PRIMARY | |||
|
200-199-6
Created by
admin on Mon Mar 31 17:47:25 GMT 2025 , Edited by admin on Mon Mar 31 17:47:25 GMT 2025
|
PRIMARY | |||
|
7BVB29RCPR
Created by
admin on Mon Mar 31 17:47:25 GMT 2025 , Edited by admin on Mon Mar 31 17:47:25 GMT 2025
|
PRIMARY | |||
|
C291
Created by
admin on Mon Mar 31 17:47:25 GMT 2025 , Edited by admin on Mon Mar 31 17:47:25 GMT 2025
|
PRIMARY | |||
|
SUB197079
Created by
admin on Mon Mar 31 17:47:25 GMT 2025 , Edited by admin on Mon Mar 31 17:47:25 GMT 2025
|
PRIMARY | |||
|
100000182789
Created by
admin on Mon Mar 31 17:47:25 GMT 2025 , Edited by admin on Mon Mar 31 17:47:25 GMT 2025
|
PRIMARY | |||
|
3206
Created by
admin on Mon Mar 31 17:47:25 GMT 2025 , Edited by admin on Mon Mar 31 17:47:25 GMT 2025
|
PRIMARY | |||
|
m2167
Created by
admin on Mon Mar 31 17:47:25 GMT 2025 , Edited by admin on Mon Mar 31 17:47:25 GMT 2025
|
PRIMARY | Merck Index | ||
|
5901
Created by
admin on Mon Mar 31 17:47:25 GMT 2025 , Edited by admin on Mon Mar 31 17:47:25 GMT 2025
|
PRIMARY | |||
|
D001380
Created by
admin on Mon Mar 31 17:47:25 GMT 2025 , Edited by admin on Mon Mar 31 17:47:25 GMT 2025
|
PRIMARY | |||
|
54-25-1
Created by
admin on Mon Mar 31 17:47:25 GMT 2025 , Edited by admin on Mon Mar 31 17:47:25 GMT 2025
|
PRIMARY | |||
|
DTXSID20960091
Created by
admin on Mon Mar 31 17:47:25 GMT 2025 , Edited by admin on Mon Mar 31 17:47:25 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD